According to Data Bridge Market Research new Market report, global radiation dose management market will account to an estimated USD 227.59 million in 2018 growing at a CAGR of 41.1% during the forecast period of 2019 to 2026. 
Access Full Report at https://databridgemarketresearch.com/reports/global-radiation-dose-management-market
Global Radiation Dose Management Market
Radiation is an emission of energy that comes from a source and has the ability to travel through space and matter. Sunlight is one of the most common radiations that provide light, heat and sultans. Radiation doze is the amount of radiation energy absorbed by the body. There are three types of doses- absorbed dose, equivalent dose and effective dose. To access the potential for biochemical changes in specific tissues, absorbed dose is used, to access how much biological damage is caused from absorbed dose, equivalent dose is used and to access the long- term effects that can be used in future, effective dose is used. Radiotherapy, mammography, computed tomography, nuclear medicine, fluoroscopy, and interventional imaging are some of the applications of the radio dose.
Segmentation: Global Radiation Dose Management Market
Global radiation dose management market is segmented on the basis of product and services, modality, end- user and geography. By Product and Sevices (Radiation Dose Management Solutions, Radiation Dose Management Services Market), Modality (Computed Tomography, Fluoroscopy and Interventional Imaging, Radiography and Mammography, Nuclear Medicine), End-User (Hospitals, Ambulatory Care Settings, Research Institutes and Academic Medical Centers), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) FACTORS DRIVING GROWTH IN RADIATION DOSE MANAGEMENT MARKET Increasing cancer cases According to WHO, in 2018 18.4 % of people died from lung cancer, 9.2% from colorectal cancer, 8.2% from stomach and liver cancer respectively, 6.6% from breast cancer, 5.3% from oesophagus cancer, 4.5% from pancreas cancer, 3.8% from prostate and 35.8% from other cancers. Approximately, 9555027 deaths happened in 2018. In U.S. approximately 891thousand new cancer cases will be there in 2019 among women and approximately 870 thousand cases among man in 2019. It is estimated that around 1762450 new cancer cases will be there in 2019. 
Key Market Competitors: Global Radiation Dose Management Market
Few of the major competitors currently working in the radiation dose management market are Bayer AG, General Electric Company, PACS Health, LLC, Bracco Imaging S.p.A, Novarad Corporation, Siemens AG, Sectra AB, Agfa Gevaert, Qaleum N.V., Fujifilm Holdings Corporation, Medsquare, INFINITT Healthcare Co. Ltd., Koninklijke Philips N.V., Thermo Fisher Scientific, Mckesson Corporation, Richardson Healthcare, sectraab, Ultraspect Inc., Medic Vision Imaging Solutions Ltd., Erlanger Health Systems and Toshiba Medical Systems Corporation.
Browse Related Reports: Global Radiation Dose Management Market
Global Urothelial Cancer Drugs Market By Type (Urothelial Carcinoma, Squamous Cell Carcinoma, Adenocarcinoma), Treatment (Chemotherapy, Immunotherapy), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026 https://databridgemarketresearch.com/reports/global-urothelial-cancer-drugs-market Global Medical Radiation Shielding Market, By Product (MRI Shielding Products, X-Ray Rooms, Lead Bricks, Lead Glass), By Solution (Radiation Therapy Shielding, Diagnostic Shielding), By End User (Hospitals, Diagnostic Centers), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends and Forecast to 2025 https://databridgemarketresearch.com/reports/global-medical-radiation-shielding-market
